-
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL StudyM .Kosiborod, CVD-REAL Investigators and Study Group. -
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart FailureWong JA, Conen D, Van Gelder IC et al.
-
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWC Levy, AS Hellkamp, DB Mark et al.
-
HFpEF: From Mechanisms to TherapiesRagavendra R. Baliga, M.B.B.S., FACC
-
Good response to tolvaptan shortens hospitalization in patients with congestive heart failureKogure T, Jujo K, Hamada K et al.
-
Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?van Everdingen WM, Zweerink A, Cramer MJ et al.
-
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist SystemsBerg DD, Vaduganathan M, Stewart GC et al.
-
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in AdultsKS Ivey, KM Edwards, HK Talbot et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
